Primity Bio

Santa Clara, United States Founded: 2008 • Age: 18 yrs Acquired By CellCarta
Multi-parameter cell analysis systems are developed for high-content screening.
Request Access

About Primity Bio

Primity Bio is a company based in Santa Clara (United States) founded in 2008 by Peter Krutzik was acquired by CellCarta in August 2018.. Primity Bio offers products and services including Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services. Primity Bio operates in a competitive market with competitors including Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.

  • Headquarter Santa Clara, United States
  • Founders Peter Krutzik
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.5 M (USD), Grant

    Jan 19, 2017

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    CellCarta

    (Aug 21, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Primity Bio

Primity Bio offers a comprehensive portfolio of products and services, including Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Analyzes clinical biomarkers for drug development applications

Provides digital PCR and RNA sequencing for research

Offers digital pathology and IHC solutions for diagnostics

Conducts assays like FACS for cellular phenotyping

Manages sample handling and biorepository solutions

People of Primity Bio
Headcount 200-500
Employee Profiles 11
Board Members and Advisors 15
Employee Profiles
People
Luc van Iseghem
SVP, Global IT
People
Dusty Tenney
CEO
People
Nancy El Sayegh
VP, General Counsel & Corporate Secretary
People
Rona Rosen
SVP, Global Human Resources

Unlock access to complete

Board Members and Advisors
people
Martin Leblanc
Co-Founder & Vice-Chairman
people
Garry Nolan
Scientific Advisor
people
Rafick - Pierre Sékaly
Scientific Advisor
people
Scott Gottlieb
Scientific Advisor

Unlock access to complete

Funding Insights of Primity Bio

  • Total Funding
  • Total Rounds 9
  • Last Round Grant — $1.5M
  • First Round

    (01 Apr 2008)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2017 Amount Grant - Primity Bio Valuation

investors

HHS
Sep, 2014 Amount Grant - Primity Bio Valuation

investors

HHS
Apr, 2014 Amount Grant - Primity Bio Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Primity Bio

Primity Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and CellCarta. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Histopathology and genomics services are offered by the CRO.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Primity Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Primity Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Primity Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Primity Bio

Primity Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Phenotypic screening platform developed to identify drug targets and pathways.
domain founded_year HQ Location
Instruments for automated molecular assays are developed using disposable cartridges.
domain founded_year HQ Location
Cell and gene therapies for multiple diseases are developed.
domain founded_year HQ Location
Developer of a drug pipeline programs for neurodegenerative diseases
domain founded_year HQ Location
AI-based platform for drug discovery and antibody detection is provided.
domain founded_year HQ Location
Protein design, synthesis, testing, and validation services are offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Primity Bio

Frequently Asked Questions about Primity Bio

When was Primity Bio founded?

Primity Bio was founded in 2008.

Where is Primity Bio located?

Primity Bio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.

Who is the current CEO of Primity Bio?

Peter Krutzik is the current CEO of Primity Bio. They have also founded this company.

What does Primity Bio do?

PrimityBio has developed a flowcytometry-based, multiparameter cell analysis system for high content screening with a focus on drug discovery applications. The companys platform performs single cell analysis at more than 10 parameters or markers per cell, at a rate of 5000 cells per second, with sensitivity in the range of 50 molecules per cell. Coupled with automation, the system can screen through 2000 compound wells per day to generate over 100,000 data points. The company also provides the Cytobank flow cytometry software which can analyze the generated data. The systems instrumentation includes a choice of flow cytometers (4, 5 and 6 laser BD LSR II flow cytometers with HTS sample units and up to 19 fluorescent channels, Fluidigm CyTOF Helios Mass Cytometer, BD Aria II Cell Sorter, Agilent VWorks-based automation platform, etc.

Who are the top competitors of Primity Bio?

Primity Bio's top competitors include 64x Bio, Phoremost and reMYND.

What products or services does Primity Bio offer?

Primity Bio offers Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services.

Who are Primity Bio's investors?

Primity Bio has 2 investors. Key investors include HHS, and CellCarta.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available